ALKBH5 modulates COL5A1 mRNA stability via m6A demethylation to promote tobacco carcinogen NNK-induced lung cancer occurrence and progression.
TL;DR
ALKBH5 drives NNK-induced lung cancer via m6A demethylation of COL5A1, promoting tumor progression, and Targeting the ALKBH5-COL5A1 axis may offer therapeutic strategies against tobacco-related cancers.
OpenAlex 토픽 ·
RNA modifications and cancer
HVDC Systems and Fault Protection
Cancer-related gene regulation
ALKBH5 drives NNK-induced lung cancer via m6A demethylation of COL5A1, promoting tumor progression, and Targeting the ALKBH5-COL5A1 axis may offer therapeutic strategies against tobacco-related cancer
APA
Yiheng Du, Li Tu, et al. (2026). ALKBH5 modulates COL5A1 mRNA stability via m6A demethylation to promote tobacco carcinogen NNK-induced lung cancer occurrence and progression.. Journal of advanced research, 83, 713-725. https://doi.org/10.1016/j.jare.2025.08.010
MLA
Yiheng Du, et al.. "ALKBH5 modulates COL5A1 mRNA stability via m6A demethylation to promote tobacco carcinogen NNK-induced lung cancer occurrence and progression.." Journal of advanced research, vol. 83, 2026, pp. 713-725.
PMID
40812588
Abstract
[INTRODUCTION] The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), has been extensively studied for its carcinogenic role in lung cancer. However, the involvement of N6-methyladenosine (m6A) methylation in NNK-induced carcinogenesis remains unclear.
[OBJECTIVES] The aim of this study is to investigatewhether NNK promotes lung carcinogenesis by dysregulating m6A methylation, focusing on the demethylase ALKBH5 and its target COL5A1.
[METHODS] Levels of m6A were analyzed in NNK-exposed (100 mg/L, 24 h) Beas-2B bronchial epithelial cells, NNK-induced malignant-transformed Beas-2B (2B-NNK) cells, and paired lung tumor tissues. Methylated RNA immunoprecipitation sequencing, RNA sequencing, and bioinformatics identified COL5A1 as a key target. We performed proliferation, apoptosis, migration and invasion experiments involving COL5A1 and ALKBH5 knockdown and COL5A1 stability experiments. We then overexpressed COL5A1 and knocked down ALKBH5 for phenotypic rescue experiments.
[RESULTS] Levels of m6A were significantly reduced in NNK-exposed Beas-2B cells, 2B-NNK cells, and human lung tumor tissues. COL5A1 exhibited hypomethylation and overexpression in 2B-NNK cells. COL5A1 knockdown suppressed 2B-NNK cell proliferation, migration, and invasion, while increasing apoptosis. The m6A demethylase ALKBH5 was upregulated in 2B-NNK cells. Its knockdown elevated global m6A levels, reduced COL5A1 mRNA stability, and reversed malignant phenotypes. COL5A1 overexpression also enhanced the proliferation, migration, and invasion abilities of 2B-NNK cells, whereas concurrent downregulation of ALKBH5 expression resulted in the restoration of these enhancements.
[CONCLUSION] ALKBH5 drives NNK-induced lung cancer via m6A demethylation of COL5A1, promoting tumor progression. Targeting the ALKBH5-COL5A1 axis may offer therapeutic strategies against tobacco-related cancers.
[OBJECTIVES] The aim of this study is to investigatewhether NNK promotes lung carcinogenesis by dysregulating m6A methylation, focusing on the demethylase ALKBH5 and its target COL5A1.
[METHODS] Levels of m6A were analyzed in NNK-exposed (100 mg/L, 24 h) Beas-2B bronchial epithelial cells, NNK-induced malignant-transformed Beas-2B (2B-NNK) cells, and paired lung tumor tissues. Methylated RNA immunoprecipitation sequencing, RNA sequencing, and bioinformatics identified COL5A1 as a key target. We performed proliferation, apoptosis, migration and invasion experiments involving COL5A1 and ALKBH5 knockdown and COL5A1 stability experiments. We then overexpressed COL5A1 and knocked down ALKBH5 for phenotypic rescue experiments.
[RESULTS] Levels of m6A were significantly reduced in NNK-exposed Beas-2B cells, 2B-NNK cells, and human lung tumor tissues. COL5A1 exhibited hypomethylation and overexpression in 2B-NNK cells. COL5A1 knockdown suppressed 2B-NNK cell proliferation, migration, and invasion, while increasing apoptosis. The m6A demethylase ALKBH5 was upregulated in 2B-NNK cells. Its knockdown elevated global m6A levels, reduced COL5A1 mRNA stability, and reversed malignant phenotypes. COL5A1 overexpression also enhanced the proliferation, migration, and invasion abilities of 2B-NNK cells, whereas concurrent downregulation of ALKBH5 expression resulted in the restoration of these enhancements.
[CONCLUSION] ALKBH5 drives NNK-induced lung cancer via m6A demethylation of COL5A1, promoting tumor progression. Targeting the ALKBH5-COL5A1 axis may offer therapeutic strategies against tobacco-related cancers.
MeSH Terms
Humans; AlkB Homolog 5, RNA Demethylase; Lung Neoplasms; Nitrosamines; RNA Stability; Carcinogens; Demethylation; Adenosine; Disease Progression; Cell Proliferation; Cell Movement; Carcinogenesis; Gene Expression Regulation, Neoplastic; Apoptosis; RNA, Messenger
같은 제1저자의 인용 많은 논문 (5)
- RBM47-Induced Gasdermin A/GSDMA Mediates Mesenchymal-Epithelial Transition and Pyroptosis of Colorectal Cancer Cells.
- NUSAP1 Recruits DAXX to Suppress HIF-Driven Triple-Negative Breast Cancer Progression.
- A long-term survival prediction model for non-small cell lung cancer based on blood inflammatory biomarkers.
- Exploring the design space for Triton X-100 substitutes in viral inactivation applications.
- A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC).